Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
Not Applicable
Completed
- Conditions
- Methamphetamine Abuse
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Affect Therapeutics, Inc.
- Target Recruit Count
- 79
- Registration Number
- NCT05266716
- Locations
- 🇺🇸
Affect Therapeutics, New York, New York, United States
Demonstration of a Digital Care Program for Methamphetamine Use Disorder
Not Applicable
Completed
- Conditions
- Methamphetamine Abuse
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Affect Therapeutics, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05206175
- Locations
- 🇺🇸
Affect Therapeutics, New York, New York, United States
News
No news found